: A Tale of Stealth and Endurance.

() , an opportunistic human fungal pathogen, causes mucosal and deep-seated infections in immunocompromised individuals. Recently designated as a high-priority fungal pathogen by the World Health Organization (WHO), exhibits low inherent susceptibility to azole antifungals. In addition, about 10% clinical isolates of display co-resistance to both azole and echinocandin drugs. Molecular mechanisms of antifungal resistance and virulence in are currently being delineated in-depth. This Review provides an overview of the epidemiology, biology, drug resistance, tools and host model systems for . Additionally, we discuss the immune evasion strategies that aid in establishing infections in the host. Overall, this Review aims to contribute to ongoing efforts to raise awareness of human pathogenic fungi, the growing threat of antifungal drug resistance and the unmet need for novel antifungal therapies, with an ultimate goal of improving clinical outcomes of affected individuals.